Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

Episode von Medizin - Open Access LMU - Teil 15/22 von Ludwig-Maximilians-Universität München · 1. Januar 2007

Aims: A number of intervention studies have shown that therapy with angiotensin receptor blockers, such as irbesartan, can improve metabolic parameters and reduce the incidence of diabetes mellitus. It is unknown whether this observation also holds true in routine clinical settings. Methods: We evaluated the effect of irbesartan (150 mg or 300 mg/d) together with or without hydrochlorothiazide (12.5 mg/d) in 3259 German patients. A total of 750 primary care physicians evaluated up to 5 subsequent patients with metabolic syndrome (58.9% diabetic), in whom irbesartan therapy was newly initiated (87%) or continued (13%). Results: Six months of irbesartan therapy decreased systolic blood pressure by 14% (157.4 +/- 14.7 vs. 135.0 +/- 10.7 mmHg) and diastolic blood pressure by 13% (92.9 +/- 9.2 vs. 80.8 +/- 6.8 mmHg). This was associated with a decrease in body weight (-2.3%), fasting glucose (-9.5%), HbA1c (-4.6%), LDL-cholesterol (-11%), triglycerides (-16%) and gamma-GT (-12%) and an increase in HDL-cholesterol (+5%). These changes were somewhat more pronounced in male than in female patients and in obese than in lean patients. Changes in glucose concentration and HbA1c were much more prominent in diabetic patients. Conclusion: Irbesartan therapy improves metabolic parameters in routine clinical settings. Thus, our study confirms previously published results from large intervention trials and extends the findings to routine clinical practice.

Weitere Episoden von „Medizin - Open Access LMU - Teil 15/22“

• Occupation and adult onset of rhinitis in the general population 1. Januar 2008
• Retention of mouth-to-mouth, mouth-to-mask and mouth-to-face shield ventilation 1. Januar 2008
• An in vivo evaluation of Brilliant Blue G in animals and humans 1. Januar 2008
• Syk-mediated translocation of PI3Kδ to the leading edge controls lamellipodium formation and migration of leukocytes 7. November 2007
• Evolutionary aspects in evaluating mutations in the melanocortin 4 receptor 1. Oktober 2007
• Natural killer cells promote early CD8 T cell responses against cytomegalovirus. 24. August 2007
• Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome 23. Mai 2007
• The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts 1. April 2007
• Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system 1. März 2007
• Antithrombin and hypercoagulability in sepsis: insights from thrombelastography? 1. Januar 2007
• Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials 1. Januar 2007
• Does respiratory health contribute to the effects of long-term air pollution exposure on cardiovascular mortality? 1. Januar 2007
• Acute childhood diarrhoea in northern Ghana: epidemiological, clinical and microbiological characteristics 1. Januar 2007
• Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent 1. Januar 2007
• Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant 1. Januar 2007

Alle Episoden von Medizin - Open Access LMU - Teil 15/22 · Mehr Bildung-Podcasts